This report contains market size and forecasts of Pirfenidone in global, including the following market information:
Global Pirfenidone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pirfenidone Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Pirfenidone companies in 2021 (%)
The global Pirfenidone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pirfenidone include Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals and Koye Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pirfenidone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pirfenidone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pirfenidone Market Segment Percentages, by Type, 2021 (%)
Tablet
Capsule
Other
Global Pirfenidone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pirfenidone Market Segment Percentages, by Application, 2021 (%)
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
Global Pirfenidone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pirfenidone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pirfenidone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pirfenidone revenues share in global market, 2021 (%)
Key companies Pirfenidone sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Pirfenidone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth